img

Global Ulcerative Colitis Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ulcerative Colitis Drugs Market Insights, Forecast to 2034

Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
Market Analysis and InsightsGlobal Ulcerative Colitis Drugs Market
Global Ulcerative Colitis Drugs market is expected to reach to US$ 8254 million in 2024, with a positive growth of %, compared with US$ 7810 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ulcerative Colitis Drugs industry is evaluated to reach US$ 11250 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Ulcerative Colitis Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ulcerative Colitis Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Roche
Sanofi
GSK
AstraZeneca
MSD
Johnson & Johnson
Bayer
AbbVie
Eli Lilly and Company
Amgen
Takeda Pharmaceuticals Company
Ferring Pharmaceuticals
InDeX Pharmaceuticals
Segment by Type
Oral
Injection

Segment by Application


Hospital
Drugs Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Ulcerative Colitis Drugs introduction, etc. Ulcerative Colitis Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Ulcerative Colitis Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ulcerative Colitis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Ulcerative Colitis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ulcerative Colitis Drugs Market Perspective (2018-2029)
2.2 Global Ulcerative Colitis Drugs Growth Trends by Region
2.2.1 Ulcerative Colitis Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ulcerative Colitis Drugs Historic Market Size by Region (2018-2024)
2.2.3 Ulcerative Colitis Drugs Forecasted Market Size by Region (2024-2029)
2.3 Ulcerative Colitis Drugs Market Dynamics
2.3.1 Ulcerative Colitis Drugs Industry Trends
2.3.2 Ulcerative Colitis Drugs Market Drivers
2.3.3 Ulcerative Colitis Drugs Market Challenges
2.3.4 Ulcerative Colitis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Ulcerative Colitis Drugs by Players
3.1.1 Global Ulcerative Colitis Drugs Revenue by Players (2018-2024)
3.1.2 Global Ulcerative Colitis Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Ulcerative Colitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Ulcerative Colitis Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Ulcerative Colitis Drugs Market Concentration Ratio
3.4.1 Global Ulcerative Colitis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Drugs Revenue in 2022
3.5 Global Key Players of Ulcerative Colitis Drugs Head office and Area Served
3.6 Global Key Players of Ulcerative Colitis Drugs, Product and Application
3.7 Global Key Players of Ulcerative Colitis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ulcerative Colitis Drugs Breakdown Data by Type
4.1 Global Ulcerative Colitis Drugs Historic Market Size by Type (2018-2024)
4.2 Global Ulcerative Colitis Drugs Forecasted Market Size by Type (2024-2029)
5 Ulcerative Colitis Drugs Breakdown Data by Application
5.1 Global Ulcerative Colitis Drugs Historic Market Size by Application (2018-2024)
5.2 Global Ulcerative Colitis Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Ulcerative Colitis Drugs Market Size (2018-2029)
6.2 North America Ulcerative Colitis Drugs Market Size by Type
6.2.1 North America Ulcerative Colitis Drugs Market Size by Type (2018-2024)
6.2.2 North America Ulcerative Colitis Drugs Market Size by Type (2024-2029)
6.2.3 North America Ulcerative Colitis Drugs Market Share by Type (2018-2029)
6.3 North America Ulcerative Colitis Drugs Market Size by Application
6.3.1 North America Ulcerative Colitis Drugs Market Size by Application (2018-2024)
6.3.2 North America Ulcerative Colitis Drugs Market Size by Application (2024-2029)
6.3.3 North America Ulcerative Colitis Drugs Market Share by Application (2018-2029)
6.4 North America Ulcerative Colitis Drugs Market Size by Country
6.4.1 North America Ulcerative Colitis Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Ulcerative Colitis Drugs Market Size by Country (2018-2024)
6.4.3 North America Ulcerative Colitis Drugs Market Size by Country (2024-2029)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Ulcerative Colitis Drugs Market Size (2018-2029)
7.2 Europe Ulcerative Colitis Drugs Market Size by Type
7.2.1 Europe Ulcerative Colitis Drugs Market Size by Type (2018-2024)
7.2.2 Europe Ulcerative Colitis Drugs Market Size by Type (2024-2029)
7.2.3 Europe Ulcerative Colitis Drugs Market Share by Type (2018-2029)
7.3 Europe Ulcerative Colitis Drugs Market Size by Application
7.3.1 Europe Ulcerative Colitis Drugs Market Size by Application (2018-2024)
7.3.2 Europe Ulcerative Colitis Drugs Market Size by Application (2024-2029)
7.3.3 Europe Ulcerative Colitis Drugs Market Share by Application (2018-2029)
7.4 Europe Ulcerative Colitis Drugs Market Size by Country
7.4.1 Europe Ulcerative Colitis Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Ulcerative Colitis Drugs Market Size by Country (2018-2024)
7.4.3 Europe Ulcerative Colitis Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Ulcerative Colitis Drugs Market Size (2018-2029)
8.2 China Ulcerative Colitis Drugs Market Size by Type
8.2.1 China Ulcerative Colitis Drugs Market Size by Type (2018-2024)
8.2.2 China Ulcerative Colitis Drugs Market Size by Type (2024-2029)
8.2.3 China Ulcerative Colitis Drugs Market Share by Type (2018-2029)
8.3 China Ulcerative Colitis Drugs Market Size by Application
8.3.1 China Ulcerative Colitis Drugs Market Size by Application (2018-2024)
8.3.2 China Ulcerative Colitis Drugs Market Size by Application (2024-2029)
8.3.3 China Ulcerative Colitis Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ulcerative Colitis Drugs Market Size (2018-2029)
9.2 Asia Ulcerative Colitis Drugs Market Size by Type
9.2.1 Asia Ulcerative Colitis Drugs Market Size by Type (2018-2024)
9.2.2 Asia Ulcerative Colitis Drugs Market Size by Type (2024-2029)
9.2.3 Asia Ulcerative Colitis Drugs Market Share by Type (2018-2029)
9.3 Asia Ulcerative Colitis Drugs Market Size by Application
9.3.1 Asia Ulcerative Colitis Drugs Market Size by Application (2018-2024)
9.3.2 Asia Ulcerative Colitis Drugs Market Size by Application (2024-2029)
9.3.3 Asia Ulcerative Colitis Drugs Market Share by Application (2018-2029)
9.4 Asia Ulcerative Colitis Drugs Market Size by Region
9.4.1 Asia Ulcerative Colitis Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Ulcerative Colitis Drugs Market Size by Region (2018-2024)
9.4.3 Asia Ulcerative Colitis Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ulcerative Colitis Drugs Introduction
11.1.4 Pfizer Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Ulcerative Colitis Drugs Introduction
11.2.4 Novartis Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Ulcerative Colitis Drugs Introduction
11.3.4 Roche Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.3.5 Roche Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Ulcerative Colitis Drugs Introduction
11.4.4 Sanofi Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.4.5 Sanofi Recent Developments
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Ulcerative Colitis Drugs Introduction
11.5.4 GSK Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.5.5 GSK Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Ulcerative Colitis Drugs Introduction
11.6.4 AstraZeneca Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 MSD
11.7.1 MSD Company Details
11.7.2 MSD Business Overview
11.7.3 MSD Ulcerative Colitis Drugs Introduction
11.7.4 MSD Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.7.5 MSD Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Ulcerative Colitis Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.8.5 Johnson & Johnson Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Ulcerative Colitis Drugs Introduction
11.9.4 Bayer Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.9.5 Bayer Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Ulcerative Colitis Drugs Introduction
11.10.4 AbbVie Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.10.5 AbbVie Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Ulcerative Colitis Drugs Introduction
11.11.4 Eli Lilly and Company Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.11.5 Eli Lilly and Company Recent Developments
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Ulcerative Colitis Drugs Introduction
11.12.4 Amgen Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.12.5 Amgen Recent Developments
11.13 Takeda Pharmaceuticals Company
11.13.1 Takeda Pharmaceuticals Company Company Details
11.13.2 Takeda Pharmaceuticals Company Business Overview
11.13.3 Takeda Pharmaceuticals Company Ulcerative Colitis Drugs Introduction
11.13.4 Takeda Pharmaceuticals Company Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.13.5 Takeda Pharmaceuticals Company Recent Developments
11.14 Ferring Pharmaceuticals
11.14.1 Ferring Pharmaceuticals Company Details
11.14.2 Ferring Pharmaceuticals Business Overview
11.14.3 Ferring Pharmaceuticals Ulcerative Colitis Drugs Introduction
11.14.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.14.5 Ferring Pharmaceuticals Recent Developments
11.15 InDeX Pharmaceuticals
11.15.1 InDeX Pharmaceuticals Company Details
11.15.2 InDeX Pharmaceuticals Business Overview
11.15.3 InDeX Pharmaceuticals Ulcerative Colitis Drugs Introduction
11.15.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Drugs Business (2018-2024)
11.15.5 InDeX Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Ulcerative Colitis Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Ulcerative Colitis Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Ulcerative Colitis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Ulcerative Colitis Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Ulcerative Colitis Drugs Market Share by Region (2018-2024)
Table 8. Global Ulcerative Colitis Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Ulcerative Colitis Drugs Market Share by Region (2024-2029)
Table 10. Ulcerative Colitis Drugs Market Trends
Table 11. Ulcerative Colitis Drugs Market Drivers
Table 12. Ulcerative Colitis Drugs Market Challenges
Table 13. Ulcerative Colitis Drugs Market Restraints
Table 14. Global Ulcerative Colitis Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Ulcerative Colitis Drugs Revenue Share by Players (2018-2024)
Table 16. Global Top Ulcerative Colitis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis Drugs as of 2022)
Table 17. Global Ulcerative Colitis Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Ulcerative Colitis Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Ulcerative Colitis Drugs, Headquarters and Area Served
Table 20. Global Key Players of Ulcerative Colitis Drugs, Product and Application
Table 21. Global Key Players of Ulcerative Colitis Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Ulcerative Colitis Drugs Revenue Market Share by Type (2018-2024)
Table 25. Global Ulcerative Colitis Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Ulcerative Colitis Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Ulcerative Colitis Drugs Revenue Share by Application (2018-2024)
Table 29. Global Ulcerative Colitis Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Ulcerative Colitis Drugs Revenue Share by Application (2024-2029)
Table 31. North America Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Ulcerative Colitis Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Ulcerative Colitis Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Ulcerative Colitis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Ulcerative Colitis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Ulcerative Colitis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Ulcerative Colitis Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Ulcerative Colitis Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Ulcerative Colitis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Ulcerative Colitis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Ulcerative Colitis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Ulcerative Colitis Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Ulcerative Colitis Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Ulcerative Colitis Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Ulcerative Colitis Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Ulcerative Colitis Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Ulcerative Colitis Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Ulcerative Colitis Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Ulcerative Colitis Drugs Product
Table 66. Pfizer Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Ulcerative Colitis Drugs Product
Table 71. Novartis Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Ulcerative Colitis Drugs Product
Table 76. Roche Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 77. Roche Recent Developments
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Ulcerative Colitis Drugs Product
Table 81. Sanofi Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 82. Sanofi Recent Developments
Table 83. GSK Company Details
Table 84. GSK Business Overview
Table 85. GSK Ulcerative Colitis Drugs Product
Table 86. GSK Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 87. GSK Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Ulcerative Colitis Drugs Product
Table 91. AstraZeneca Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. MSD Company Details
Table 94. MSD Business Overview
Table 95. MSD Ulcerative Colitis Drugs Product
Table 96. MSD Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 97. MSD Recent Developments
Table 98. Johnson & Johnson Company Details
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Ulcerative Colitis Drugs Product
Table 101. Johnson & Johnson Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 102. Johnson & Johnson Recent Developments
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Ulcerative Colitis Drugs Product
Table 106. Bayer Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 107. Bayer Recent Developments
Table 108. AbbVie Company Details
Table 109. AbbVie Business Overview
Table 110. AbbVie Ulcerative Colitis Drugs Product
Table 111. AbbVie Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 112. AbbVie Recent Developments
Table 113. Eli Lilly and Company Company Details
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Ulcerative Colitis Drugs Product
Table 116. Eli Lilly and Company Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 117. Eli Lilly and Company Recent Developments
Table 118. Amgen Company Details
Table 119. Amgen Business Overview
Table 120. Amgen Ulcerative Colitis Drugs Product
Table 121. Amgen Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 122. Amgen Recent Developments
Table 123. Takeda Pharmaceuticals Company Company Details
Table 124. Takeda Pharmaceuticals Company Business Overview
Table 125. Takeda Pharmaceuticals Company Ulcerative Colitis Drugs Product
Table 126. Takeda Pharmaceuticals Company Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 127. Takeda Pharmaceuticals Company Recent Developments
Table 128. Ferring Pharmaceuticals Company Details
Table 129. Ferring Pharmaceuticals Business Overview
Table 130. Ferring Pharmaceuticals Ulcerative Colitis Drugs Product
Table 131. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 132. Ferring Pharmaceuticals Recent Developments
Table 133. InDeX Pharmaceuticals Company Details
Table 134. InDeX Pharmaceuticals Business Overview
Table 135. InDeX Pharmaceuticals Ulcerative Colitis Drugs Product
Table 136. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Drugs Business (2018-2024) & (US$ Million)
Table 137. InDeX Pharmaceuticals Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ulcerative Colitis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Ulcerative Colitis Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Ulcerative Colitis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Ulcerative Colitis Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Drugs Stores Case Studies
Figure 9. Ulcerative Colitis Drugs Report Years Considered
Figure 10. Global Ulcerative Colitis Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Ulcerative Colitis Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Ulcerative Colitis Drugs Market Share by Region: 2022 VS 2029
Figure 13. Global Ulcerative Colitis Drugs Market Share by Players in 2022
Figure 14. Global Top Ulcerative Colitis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Ulcerative Colitis Drugs Revenue in 2022
Figure 16. North America Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Ulcerative Colitis Drugs Market Share by Type (2018-2029)
Figure 18. North America Ulcerative Colitis Drugs Market Share by Application (2018-2029)
Figure 19. North America Ulcerative Colitis Drugs Market Share by Country (2018-2029)
Figure 20. United States Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Ulcerative Colitis Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Ulcerative Colitis Drugs Market Share by Type (2018-2029)
Figure 24. Europe Ulcerative Colitis Drugs Market Share by Application (2018-2029)
Figure 25. Europe Ulcerative Colitis Drugs Market Share by Country (2018-2029)
Figure 26. Germany Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Ulcerative Colitis Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Ulcerative Colitis Drugs Market Share by Type (2018-2029)
Figure 34. China Ulcerative Colitis Drugs Market Share by Application (2018-2029)
Figure 35. Asia Ulcerative Colitis Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Ulcerative Colitis Drugs Market Share by Type (2018-2029)
Figure 37. Asia Ulcerative Colitis Drugs Market Share by Application (2018-2029)
Figure 38. Asia Ulcerative Colitis Drugs Market Share by Region (2018-2029)
Figure 39. Japan Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Ulcerative Colitis Drugs Market Share by Country (2018-2029)
Figure 49. Brazil Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Ulcerative Colitis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 56. Novartis Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 57. Roche Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 59. GSK Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 60. AstraZeneca Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 61. MSD Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 62. Johnson & Johnson Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 63. Bayer Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 64. AbbVie Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 66. Amgen Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 67. Takeda Pharmaceuticals Company Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 68. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 69. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Drugs Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries